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Summary 
CD8 + T cells have suppressor effector functions, but the mechanisms involved in the generation 
of this activity are poorly understood. We report that natural killer (NK) ceils have an important 
role in the acquisition of this function.  CD8 § cells induce NK cells to produce transforming 
growth factor-fl (TGF-fl) which,  in turn,  stimulates  CD8 + T  cells  to become suppressors of 
antibody production. Using a monocyte-dependent and -independent method to induce antibody 
production,  we first  observed that  the  addition  of NK cells to CD8 + cells  was required  for 
optimal suppression. Next, we determined that the interaction of CD8 + T  cells with NK cells 
resulted in a striking increase NK cell TGF-fl mRNA and its production. This cytokine appeared 
to be involved in the induction of T  suppressor cell activity since:  (a) anti-TGF-fll completely 
abrogated the suppression of immunoglobulin G synthesis; (b) TGF-fll could substitute for NK cells 
in inducing  CD8 + T  cells  to develop suppressor activity;  and (c) a short exposure of T  cells 
to TGF-fll in the absence of B cells was sufficient for the generation of suppressor activity by 
CD8 + T  ceUs. Interferon y  did not have this property. These studies provide strong evidence 
that  in addition  to its  suppressive properties,  TGF-fl is involved in the  generation  of CD8 + 
T  suppressor effector cells. Because NK cell function is decreased in many autoimmune diseases, 
these cells may fail to interact properly with these individuals'  CD8 ~ cells in generating  sup- 
pressors of aggressive anti-self responses. 
utoimmune diseases  occur in genetically susceptible in- 
dividuals  after the breakdown  of self-tolerance.  Sup- 
pressor lymphocytes represent one mechanism that normally 
protects  against  autoimmunity  (1,  2).  CD8 + T  cells  have 
well-recognized suppressor functions, but in SLE, for example, 
CD8 + T  cells enhance rather than suppress B cell function 
for reasons that are not fully understood (3).  In addition to 
their cytolytic functions, NK cells also have suppressive prop- 
erties (4-6). NK cell activity is decreased in autoimmune dis- 
eases such as SLE (7), Sjogren's syndrome (8), and multiple 
sclerosis (9). The regulatory role of NK cells is unclear since 
these cells have also been shown to  support Ig production 
(10-12). Mechanisms reported to be involved in NK cell regula- 
tory effects have included perturbation of Fcy receptors (CD16) 
(6), or NK cell-derived cytokines such as TNF-ol and IFN-y 
(4,  12). 
Another cytokine that has prominent  effects on host de- 
fense is TGF-fl.  Mice with  an inherited  deficiency of this 
cytokine develop a multifocal inflammatory disease that results 
in organ failure and ultimately, in death (13). TGFfl is a mul- 
tifunctional cytokine with predominantly suppressive effects 
on the immune system (14). Recently, TGFfl has been reported 
to  selectively  activate  CD8 +  T  cells  to  proliferate  (15). 
Herein,  we  report  a  novel  interaction  between  NK  and 
CD8 + T  cells resulting in the generation of TGFfl, which, 
in turn,  becomes involved in the activation of CD8 + lym- 
phocytes to become suppressor  effectors of antibody pro- 
duction. 
Materials and Methods 
Cell Isohtion.  PBMC were prepared from heparinized venous 
blood of healthy adult volunteers by Ficoll-Hypaque (Pharmacia, 
Piscataway, NJ) density gradient centrifugation. To obtain NK ceils, 
PBMC was added to a nylon wool column and the eluted, nonad- 
herent cells were immediately rosetted  with AET-treated SRBC 
(16). The nonrosetting  fraction was then stained with anti-CD3 
and anti-CD74 (anti-HLA-DP,) antibodies and depleted of reacting 
cells using immunomagnetic beads (Dynal, Great Neck, NY). This 
resultant  population  usually contained  >98% CDllb +, <0.5% 
CD3 +, and <0.5% CD20 § ceils. 
B cells were prepared by recovering the nylon adherent ceils and 
immediately rosetting the recovered ceils. The nonrosetting  frac- 
tion was depleted of monocytes and functional NK cells by incuba- 
tion with 40 mM L-leucine methyl ester (17). The resultant popu- 
lation  was usually >92% CD20 § and <0.5%  CD3 § 
CD4 + and CD8 § cells were prepared from the nylon nonad- 
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and CD74. The same antibodies were used to obtain CD8 § cells 
except that CD4 was substituted for CDS. Monocytes were pre- 
pared by adhering PBMC to plastic.  After vigorous washing, the 
adherent  cells  were  recovered by scraping  using  a  cell  scraper 
(GIBCO BRL, Gaithersburg, MD). Monocytes were irradiated with 
3,000 tad from a  137 cesium source. 
Reagents.  Antibodies used were anti-CD3 (454, a gift from W. 
Stohl, University of Southern California; anti-CD3, purchased from 
Dako Corp.,  Carpinteria,  CA),  anti-CD4 (408,  W.  Stohl; anti- 
CD3, Dako), anti-CD8 (284.1.3, W. Stohl; anti-CD8, Dako), anti- 
CDllb (OKM1, American Type Culture Collection [ATCC], Kock- 
ville,  MD),  anti-CD20  (Leu 16,  Becton Dickinson),  anti-CD74 
(L243,  ATCC), anti-CD56 (Coulter Immunology, Hialeah, FL), 
and anti-CD2 (GT2,19. Cantrell, Imperial Cancer Research Fund, 
London,  UK and OKTll,  ATCC). Chicken anti-human TGFB 
and chicken Ig were purchased from R&D Systems,  Inc.  (Min- 
neapolis, MN). 
Recombinant human IL-2 was kindly provided by Cetus, Corp. 
(EmeryviUe,  CA) and TGF-fl was purchased from R&D Systems. 
Recombinant IFN-  T was kindly provided by Genentech (South San 
Francisco,  CA). 
T Cell-dependent Antibody Production.  Cultures were carried out 
in RPMI  1640 medium (Irvine Scientific,  Santa Ana,  CA) sup- 
plemented with  10% heat-inactivated FCS (Gemini Bioproducts 
Inc., Calabasas, CA), 10 g/ml gentamicin (Irvine Scientific),  2 mM 
r-glutamine (Flow Laboratories, McLean, VA), and 10 mM Hepes 
(United States Biochemical Corp.,  Cleveland,  OH). 
Where PWM was used to induce antibody synthesis, NK cells 
were cultured overnight at 37~  in the presence or absence of 100 
U/ml rib2. These cells were then extensively washed before being 
added to culture wells. 0.5  x  10  s CD4 + T and B cells were added 
to the wells of a 96-well flat bottom microtiter plate (Flow Labora- 
tories) along with 3  x  104 monocytes (plastic adherent cells ir- 
radiated with 3,000 rad).  CD8*  or NK cells were added gener- 
ally at 0.5  x  10  s cells  per well although  in  some experiments 
graded concentrations of each were added to determine maximum 
regulatory effects.  PWM (Sigma Chemical Co., St. Louis,  MO) 
was added to the wells at 0.1/~g/ml.  After 7 d  at 37~  in 5% 
C02, cell-free supernatants from these cultures were harvested and 
assayed for IgG content by an ELISA, performed as previously de- 
scribed (5). Where anti-CD2 mAbs were used to induce antibody 
production,  the NK ceils  were not treated with II.-2. 
Cytokine  mRNA  and  TGFfl Measurement.  NK  cells,  CD8 + 
cells, or both were added to CD4 + cells,  B cells, and monocytes 
which were then cultured in the presence of PWM.  After 6 or 
18 h, the cultures were stained with CD56-PE and CD8-FITC and 
then sorted by flow cytometry by positive selection. These cells 
were pelleted and processed for PCR analysis. Cytoplasmic R.NA 
was extracted and cDNA was synthesized and amplified using ap- 
propriate primers whose sequences have been reported (18, 19). In 
two experiments, the NK cells were isolated after 18 h of incuba- 
tion and cultured for a further 72 h. The supernatants were col- 
lected and assayed for TGFfl activity using an ELISA purchased 
from Genzyme Corp. (Cambridge, MA) and performed according 
to the manufacturer's instructions. 
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Figure  1.  Marked suppression of antibody production requires both 
CD8 + and NK cells. To B ceils and irradiated monocytes (104) cultured 
with PWM were added CD4 + ceils, (solid Mrs), CD4 + and CD8 + cells 
(light hatched bars), CD4 + and NK ceils (stippled bars), and CD4 +  , CD8 + , 
and NK cells (dark hatched bars). The NK cells had been pretreated with 
rib2  (100 U/ml).  All  lymphocyte  subsets were  added at  5  x  104 
cells/well. After 7 d of culture with PWM, supernatants were harvested 
from the wells and assayed for IgG content (ng/ml) by an ELISA. (Open 
bars) Background IgG in cultures. 
ally resulted in only modest inhibition of antibody synthesis. 
These studies suggested that an additional mononuclear cell 
population was needed for the generation of potent suppressor 
activity. We considered that NK cells might have this prop- 
erty.  We first tested this hypothesis using PWM  to induce 
antibody synthesis. Neither the addition of CD8 + cells,  NK 
cells, nor both together markedly suppressed antibody syn- 
thesis. Whereas the addition of IL-2-activated NK cells did 
not have this effect, the combination of activated  NK and 
CD8 § cells markedly suppressed Ig production in eight sep- 
arate experiments. Three experiments illustrating the range 
of effects observed are shown in Fig. 1. The suppressive effect 
of adding both NK and CD8 §  cells was not due to altera- 
tions in the number of cells in the wells since increased numbers 
Table  1.  Suppression of lgM and IgG Requires Both CD8 + 
and NK Cells 
Exp.  1  Exp.  2 
Added  to PWM 
cultures  IgM  IgG  IgM  lgG 
Medium  4,100  875  2,800  440 
CD8  3,000  650  2,400  460 
NKIL-2  3,900  550  5,200  460 
CD8 + NKIL-2  260  145  840  280 
Results 
Using  two different  methods  to assess T  cell-dependent 
B  cell  differentiation,  we  observed  that  the  addition  of 
CD8 + ceils to cultures containing CD4 + and B  cells gener- 
PWM cultures consisted of CD4 + cells, B cells, irradiated (3,000 rad) 
monocytes, and PWM at the concentrations indicated in Fig. 1. To the 
cultures were  added medium,  CD8+  cells, and/or  NK cells at 5  x 
104/well each. After 7 d of culture, supernatants were harvested and as- 
sayed for IgM and IgG content  by an ELISA. 
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Figure  2.  Marked suppression of antibody production in a monocyte- 
independent system requires both CD8 + and NK cells.  CD4 + (5  x  104) 
and B cells (5  x  104) were cultured in the presence of a mitogenic com- 
bination of anti-CD2 antibodies (OKT11 and GT2).  Added to the wells 
were CD8 + cells (5  x  104) and/or untreated NK cells (5  x  104). After 
7 d  of culture,  supernatants were assayed for IgG content by an ELISA. 
of CD8 § or NK cells alone were ineffective. In addition to 
suppression of IgG, IgM production was also markedly sup- 
pressed as  shown in Table  1. 
We have recently reported that  one can assess the direct 
effects of T cells on B cells in the absence of exogenous acces- 
sory cells with a mitogenic combination of anti-CD2 mAbs 
(20). As shown in Fig. 2, with this second method we also 
observed that  the addition  of CD8 + T  cells  to CD4 + and 
B cells had modest suppressive effects.  The addition of NK 
cells generally enhanced antibody production. Since NK cells 
display CD2 receptors,  these cells were not pretreated with 
IL-2. Nonetheless, the presence of both CD8 + and NK cells 
resulted  in  optimal  suppression  of IgG  synthesis. 
As many lymphocyte functions can be mediated by cyto- 
kines,  the expression of cytokine mRNA was measured to 
identify possible candidates  for the suppressive effect. Cytokine 
mtLNA expression by CD8 + and NK cells was determined 
after these cells were cultured separately or together in PWM- 
stimulated cultures.  After 6 h  of incubation,  CD8 + T  and 
CD56 + NK cells were sorted by positive selection. The iso- 
lated cell populations were then analyzed for the expression 
of cytokine mRNA by PCR.  Cytokines produced by NK 
and CD8 + cells  include  TNF-ot,  TNF-/~  and  IFN-3~ (21). 
Because  of the  inhibitory  effects  of TGFB  (22,  23),  this 
cytokine was also examined. 
There was only one consistent result of culturing both NK 
and CD8 + cells together. This was a marked increase in NK 
cell TGF/~  mRNA.  In some experiments,  there was also a 
modest increase in CD8 + cell TGF3 mRNA and an increase 
in NK cell IFN-3~ transcripts.  Two experiments  are shown 
in  Fig.  3. 
Using a similar protocol, two additional experiments were 
performed where NK cells were isolated after an overnight 
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Figure  3.  Cytokine mRNA expression in NK 
and/or CD8 § cells after these cells were cultured 
separately or together. PWM cultures containing 
CD4 +  cells  (106),  B  cells  (106),  and  irradiated 
(3,000 tad) monocytes were cultured with:  lane 
I,  IL-2-pretreated NK cells (106);  lane 2,  CD8 + 
calls  (106);  lane  3,  NK  cells  after  culture  with 
CD8  cells; and lane 4,  CD8 +  cells after cu]ture 
with NK cells. After 6 h at 37~  in 3-ml culture 
tubes, the cells were stained with anti-CD56-PE 
and anti-CD8-FITC and sorted by flow cytometry 
for NK and CD8 cells.  Calls were then processed 
for PCR  analysis.  A  similar pattern of cytokine 
expression was  observed after  18  h  of culture. PWM-stimulated  cultures 
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Figure  4.  Anti-TGF~ abolished NK-CD8 cell-induced suppression. Cul- 
tures were initiated as described in the legend to Fig.  1. Added to these 
cultures were different concentrations of anti-TGFB antibody (0.5-10/zg/ml) 
or similar concentrations of control chicken antibody. 
incubation and cultured for an additional 72 h. When cul- 
ture supernatants were assayed for TGF~ by an ELISA, NK 
cells isolated from cultures containing CD8 + cells produced 
660 pg/ml, whereas in the absence of CD8 + cells TGFB was 
<50 pg/ml. 
These results raised the possibility that production of TGFB 
might be important in the generation of suppressor activity. 
To test this hypothesis,  the effect of anti-TGF/3 on IgG produc- 
tion was determined.  Graded doses of anti-TGFB antibody 
were added to PWM-stimulated cultures containing both IL- 
2-treated  NK and  CD8 + cells.  As shown in Fig.  4,  anti- 
TGF/3, but not the control antibody reversed the suppressive 
effects. These results demonstrate that TGF/3 contributes to 
the  suppression  of IgG  secretion. 
Since NK cells can act as a source of TGF/3, we determined 
whether TGF/3 could take the place of NK cells in the gener- 
ation of suppressive activity by CD8 + cells.  Because of the 
known suppressive effects of this cytokine on antibody produc- 
tion, we first added graded doses of TGF~ to CD4 + and B 
cells to determine the minimum  concentration  that would 
not be directly inhibitory. This concentration of TGF~ (0.5 
ng/ml) was then added to cultures where CD8 + cells were 
present or absent. Cultures containing both CD8 + and NK 
cells served as the positive control.  In each of three separate 
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Figure  5.  TGF/3 can substitute for NK cells in the generation of T 
cell suppressor activity, TGF/3 (0.5 ng/ml) or medium was added to PWM 
cultures containing CD4 + cells,  B cells, and irradiated monocytes with 
or without CD8 + cells as described in the legend to Fig. 1. Some PWM 
cultures received both CD8 § and NK cells that had been incubated with 
100 U/ml rlL-2.  After 7  d  of culture,  supernatants were assayed  for Ig 
content by an ELISA. 
experiments, we have observed that the effects of adding ei- 
ther TGFB or NK cells to CD8 + cells are similar.  In each 
case, there was marked suppression of IgG production. Fig. 
5 shows one representative  experiment. 
These observations suggested that TGFB was involved in 
the activation of CD8 + T cells to become suppressors of an- 
tibody production. However, other explanations  included the 
priming  of B cells by TGF/~  to become susceptible to the 
action of suppressor cells. To address this, two-stage experi- 
ments were performed where T  cells were stimulated with 
PWM overnight in the presence or absence of TGF/~.  The 
cells were then extensively washed before being added to B 
cells.  Exposure  of either  CD4 +  or  CD8 §  cells  alone  to 
TGF~ did not induce any suppressive activity. However, this 
activity did develop when cultures containing  both CD4 § 
and CD8 + cells were preincubated with TGF/3.  Both IgG 
and IgM production  were significantly inhibited  (Fig.  6). 
IFN-7 is another cytokine reported to be associated with 
the development of suppressor activity (24). Therefore, a di- 
rect comparison was made between TGFB and  IFN-7 for 
their ability to induce suppressor activity using the two-step 
culture system. As before, preincubation of cultures containing 
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Figure  6.  T lymphocytes prein- 
cubated with TGFfl mediate sup- 
pression. CD4 + cells, CD8 + cells, 
or  both  were  cultured  overnight 
with  irradiated  monocytes  and 
PWM in the presence or absence of 
TGF/3 (0.1 ng/ml).  Next day,  the 
wells were extensively washed.  B 
cells  and  fresh  PWM  were  then 
added to all the wells. In the case 
of the  CD8 +  only wells,  CD4 + 
cells were also added in the second 
culture. All cell concentrations were 
as described the legend to Fig. 1. 8000" 
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Figure  7.  Comparison  of  TGF3 and IFN-3' on the development  of sup- 
pressive activity was as described  in Fig. 6, except that IFN-y (100 U/ml) 
was also tested. 
both  CD4 +  and  CD8 +  cells  with  TGF3  stimulates  sup- 
pressor activity. However, IFN-% over a wide range of con- 
centrations,  did not  have any suppressive effect (Fig.  7). 
Discussion 
In this  study,  CD4 + cells were unable to induce CD8 + 
cells to become potent suppressors of antibody production. 
It  has  been well established  that  CD4 +  CD45RA +  cells 
have  important  roles in  the development  of CD8 + T  cell 
suppressor activity (25).  Here we show that NK cells were 
also required for the development of optimal suppressor ac- 
tivity.  This  finding  was observed using both a monocyte- 
dependent and -independent culture system to induce poty- 
donal B  cell activation. 
Previously, mechanisms responsible for the suppression of 
antibody production by NK cells were poorly understood. 
The  addition  of NK calls  to PBMC could either decrease 
CD4 + cell helper activity or increase CD8 + cell suppressor 
activity. On the basis of the present experiments, the former 
possibility  is  unlikely  since  the  addition  of NK  cells  to 
CD4 + and B cells did not notably decrease antibody produc- 
tion. In fact, when antibody production was stimulated with 
anti-CD2,  NK cells enhanced the amount of antibody pro- 
duced. What we have demonstrated is that  the generation 
of suppression requires  both  NK and  CD8 + cells.  When 
PWM was used to induce antibody production, the NK cells 
had to be preactivated with IL-2 in order for suppression to 
occur. When anti-CD2 was used, however, this was not the 
case because NK cells express CD2 on their cell surface and 
have been reported  to be activated by these mAbs. 
To identify potentially critical cytokines that might be in- 
volved in the activation of suppression, we examined NK and 
CD8 + cells for cytokine mRNA after they were cultured to- 
gether or separately in PWM-stimulated cultures.  The striking 
observation was the upregulation of TGF3 mRNA in NK 
cells that had been cultured together with CD8 + cells. NK 
cells isolated from cultures containing CD8 + ceils produced 
TGF3,  whereas the  absence of CD8 + cells,  little  or none 
was produced. Although TGF3 message has been described 
previously in  activated NK cells  (26),  this,  to our knowl- 
edge, is the first report of this cytokine produced by these 
cells. Moreover, the TGFB detected in the supernatant  was 
in the active form, indicating that conversion from the latent 
form had  occurred. 
Evidence that TGF/3 was actually involved in the genera- 
tion of suppressor cell activity was provided by (a) the obser- 
vation that  anti-TGF3  abolished the suppressive effects of 
the NK-CD8 + cell interaction;  and (b) the ability of TGF3 
to replace NK cells in generating  optimal CD8 § cell sup- 
pressor cell activity. It is important  to emphasize that with 
the low concentration  of TGF3 used, there was no inhibi- 
tory effect of this cytokine on IgG production in the absence 
of CD8 + cells. 
TGF3 is an immunosuppressive cytokine with marked in- 
hibitory effects on T, B, and NK cell effector functions (14). 
It is interesting to note that although TGF3 had a marked 
effect on antibody production, proliferative activity in PWM 
cultures was unaffected by TGF3 (data not shown). This sug- 
gests that some cellular functions are more susceptible to the 
effects of TGF3 than others. In addition to downregulating 
effector functions, the present study suggests that this cytokine 
can also activate lymphocytes to develop suppressive effects. 
This suggestion is consistent with the recent demonstration 
that TGF3 selectively stimulates CD45RBhi CD8 + cells to 
proliferate  (15).  Moreover, in chickens,  there is one report 
that TGF3 is important in the generation of CD8 + cell sup- 
pressor activity (27).  Other positive effects on the growth 
and development of lymphocyte subsets have been reported 
(28,  29).  Our  results  demonstrate  that  TGF3  alone  is 
insufficient  to stimulate  CD8 + ceils  to become suppressor 
effector cells but that CD4*  cells are also required.  This is 
wholly consistent with previous reports describing the role 
of CD4 + cell suppressor inducer cells. Our data indicate that 
for optimal  suppression of Ig production,  CD4 + cells  and 
a source of TGF3  are needed. 
As stated above, NK cell function  is decreased in many 
autoimmune diseases including SLE, Sjogren's syndrome, and 
multiple  sclerosis  (7-9).  If NK cells interact  with  CD8 § 
cells in a manner similar in vivo as they do in this in vitro 
model, then impaired NK cell function may reflect a defect 
that contributes to the inability of CD8 + cells to effectively 
suppress the aggressive anti-self responses in these diseases. 
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